- Home
- CAEP vs QTRX Comparison
CAEP vs QTRX Comparison
Compare CAEP & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAEP
- QTRX
- Stock Information
- Founded
- CAEP 2020
- QTRX 2007
- Country
- CAEP United States
- QTRX United States
- Employees
- CAEP N/A
- QTRX N/A
- Industry
- CAEP
- QTRX Biotechnology: Laboratory Analytical Instruments
- Sector
- CAEP
- QTRX Industrials
- Exchange
- CAEP NYSE
- QTRX Nasdaq
- Market Cap
- CAEP 276.4M
- QTRX 233.5M
- IPO Year
- CAEP 2025
- QTRX 2017
- Fundamental
- Price
- CAEP $10.49
- QTRX $6.80
- Analyst Decision
- CAEP
- QTRX Buy
- Analyst Count
- CAEP 0
- QTRX 5
- Target Price
- CAEP N/A
- QTRX $15.60
- AVG Volume (30 Days)
- CAEP 2.1M
- QTRX 895.5K
- Earning Date
- CAEP 01-01-0001
- QTRX 08-07-2025
- Dividend Yield
- CAEP N/A
- QTRX N/A
- EPS Growth
- CAEP N/A
- QTRX N/A
- EPS
- CAEP N/A
- QTRX N/A
- Revenue
- CAEP N/A
- QTRX $135,688,000.00
- Revenue This Year
- CAEP N/A
- QTRX N/A
- Revenue Next Year
- CAEP N/A
- QTRX $14.49
- P/E Ratio
- CAEP N/A
- QTRX N/A
- Revenue Growth
- CAEP N/A
- QTRX 7.71
- 52 Week Low
- CAEP $10.31
- QTRX $4.05
- 52 Week High
- CAEP $10.71
- QTRX $16.74
- Technical
- Relative Strength Index (RSI)
- CAEP N/A
- QTRX 64.53
- Support Level
- CAEP N/A
- QTRX $6.42
- Resistance Level
- CAEP N/A
- QTRX $7.09
- Average True Range (ATR)
- CAEP 0.00
- QTRX 0.46
- MACD
- CAEP 0.00
- QTRX 0.06
- Stochastic Oscillator
- CAEP 0.00
- QTRX 90.48
About CAEP CANTOR EQUITY PARTNERS III INC
Cantor Equity Partners III Inc is a blank check company.
About QTRX Quanterix Corporation
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.